Whether finding new treatments for schizophrenia or first-time ways to tackle bladder cancer, these companies are finding ...

With 30% of COPD cases misdiagnosed, experts call for improved diagnostic strategies, better disease classification, and ...

China: A recent multicenter randomized controlled trial has highlighted the potential benefits of acupuncture as a ...

Dupilumab added to standard COPD triple therapy reduces the annual rate of moderate exacerbations but not severe exacerbations.

Dupilumab vs placebo was linked to improved health-related quality of life and respiratory symptoms in patients with COPD and T2 inflammation.

With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...

SAN MARCOS, CA, USA I March 18, 2025 I SMSbiotech has announced a significant milestone in its pursuit of its regenerative medicine technology, securing ...

Ohtuvayre has Food and Drug Administration (FDA) approval for the ongoing treatment of chronic obstructive pulmonary disease (COPD) in adults. Ohtuvayre belongs to the drug class phosphodiesterase ...

SGLT2 inhibitors and GLP-1RAs yielded lower risks for COPD exacerbation than DPP-4 inhibitors among patients with type 2 diabetes.

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...